SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,486.86 |
| Enterprise Value ($M) | 1,535.39 |
| Book Value ($M) | 166.82 |
| Book Value / Share | 0.72 |
| Price / Book | 8.91 |
| NCAV ($M) | 115.35 |
| NCAV / Share | 0.50 |
| Price / NCAV | 12.89 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.27 |
| Return on Assets (ROA) | -0.30 |
| Return on Equity (ROE) | -0.53 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.64 |
| Current Ratio | 4.88 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 246.11 |
| Assets | 297.58 |
| Liabilities | 130.76 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 124.46 |
| Operating Income | -63.28 |
| Net Income | -66.07 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -89.72 |
| Cash from Investing | -131.25 |
| Cash from Financing | 146.29 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Janus Henderson Group Plc | 10.60 | 24.70 | |
| 13G | Vanguard Group Inc | 5.61 | ||
| 13G/A | Millennium Management Llc | 0.00 | -99.94 | |
| 13G/A | State Street Corp | 7.37 | -23.78 | |
| 13G | BlackRock Inc. | 7.20 | 198.03 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 867,186 | 4,895,712 | 17.71 | |
| 807,263 | 3,281,137 | 24.60 | |
| 1,023,898 | 4,066,965 | 25.18 | |
| 1,095,164 | 1,370,285 | 79.92 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| APLT – Applied Therapeutics, Inc. | AQST – Aquestive Therapeutics, Inc. |
| ARCT – Arcturus Therapeutics Holdings Inc. | ATAI – Atai Life Sciences N.V. |
| ATXS – Astria Therapeutics, Inc. |